MPM
TMO icon

Meritage Portfolio Management’s Thermo Fisher Scientific TMO Stock Holding History

Meritage Portfolio Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$799K Sell
1,379
-31
-2% -$17.5K 0.05% 187
2025
Q3 		$684K Hold
1,410
– – 0.05% 206
2025
Q2 		$572K Sell
1,410
-75
-5% -$31.4K 0.04% 234
2025
Q1 		$739K Sell
1,485
-14
-0.9% -$7.58K 0.05% 210
2024
Q4 		$780K Sell
1,499
-11
-0.7% -$6.05K 0.05% 214
2024
Q3 		$934K Hold
1,510
– – 0.06% 204
2024
Q2 		$835K Hold
1,510
– – 0.05% 208
2024
Q1 		$878K Sell
1,510
-176
-10% -$98.8K 0.06% 205
2023
Q4 		$895K Buy
+1,686
New +$816K 0.06% 207
2022
Q1 		– Sell
-11,210
Closed -$7.48M – 381
2021
Q4 		$7.48M Buy
11,210
+118
+1% +$73.7K 0.42% 62
2021
Q3 		$6.34M Buy
11,092
+122
+1% +$67K 0.38% 69
2021
Q2 		$5.53M Buy
10,970
+292
+3% +$138K 0.33% 86
2021
Q1 		$4.87M Buy
10,678
+1,888
+21% +$901K 0.32% 89
2020
Q4 		$4.09M Buy
8,790
+547
+7% +$256K 0.3% 73
2020
Q3 		$3.64M Buy
8,243
+62
+0.8% +$25.6K 0.33% 71
2020
Q2 		$2.96M Sell
8,181
-364
-4% -$122K 0.28% 103
2020
Q1 		$2.42M Sell
8,545
-306
-3% -$96.5K 0.33% 92
2019
Q4 		$2.88M Sell
8,851
-158
-2% -$47.9K 0.25% 138
2019
Q3 		$2.62M Buy
9,009
+7,154
+386% +$2.05M 0.25% 149
2019
Q2 		$545K Buy
+1,855
New +$511K 0.06% 187
2013
Q4 		– Sell
-76,830
Closed -$7.08M – 210
2013
Q3 		$7.08M Buy
76,830
+2,970
+4% +$269K 0.92% 14
2013
Q2 		$6.25M Buy
+73,860
New +$6.15M 0.9% 16

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Meritage Portfolio Management's TMO Position: Q4 2025 in Review

Meritage Portfolio Management reduced its Thermo Fisher Scientific (TMO) stake by 2.2% in Q4 2025, selling an estimated $17.5K and leaving 1,379 shares worth $799K. The position accounts for 0.05% of the portfolio, ranked #187.

Meritage Portfolio Management first reported a position in TMO in Q2 2013 and has held it in 22 quarters since. The position peaked at $7.48M in Q4 2021. 2,704 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Meritage Portfolio Management held 1,379 shares of Thermo Fisher Scientific worth $799K as of Q4 2025.
  • Meritage Portfolio Management sold 31 Thermo Fisher Scientific shares in Q4 2025, an estimated $17.5K.
  • Thermo Fisher Scientific made up 0.05% of Meritage Portfolio Management's portfolio in Q4 2025, its #187 holding.
  • Meritage Portfolio Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 22 quarters since.
  • Meritage Portfolio Management's Thermo Fisher Scientific position peaked at $7.48M in Q4 2021.
  • 2,704 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.